These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 3038391

  • 21. Altered angiotensin-converting enzyme in lung and extrapulmonary tissues of hypoxia-adapted rats.
    Oparil S, Narkates AJ, Jackson RM, Ann HS.
    J Appl Physiol (1985); 1988 Jul; 65(1):218-27. PubMed ID: 2841276
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
    Grinshtein SV, Binevski PV, Gomazkov OA, Pozdnev VF, Nikolskaya II, Kost OA.
    Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies.
    Perich RB, Jackson B, Rogerson F, Mendelsohn FA, Paxton D, Johnston CI.
    Mol Pharmacol; 1992 Aug; 42(2):286-93. PubMed ID: 1325031
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B, Schoemaker RG, van Gilst WH, van Veldhuisen DJ, Buikema H.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):141-9. PubMed ID: 16310764
    [Abstract] [Full Text] [Related]

  • 31. Radioimmunoassay for the quantitation of lisinopril and enalaprilat.
    Worland PJ, Jarrott B.
    J Pharm Sci; 1986 May 19; 75(5):512-6. PubMed ID: 3016233
    [Abstract] [Full Text] [Related]

  • 32. A deeply recessed active site in angiotensin-converting enzyme is indicated from the binding characteristics of biotin-spacer-inhibitor reagents.
    Bernstein KE, Welsh SL, Inman JK.
    Biochem Biophys Res Commun; 1990 Feb 28; 167(1):310-6. PubMed ID: 2155615
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Comparative pharmacokinetics and pharmacodynamics of lisinopril and enalapril, alone and in combination with propranolol.
    Bendtsen F, Henriksen JH.
    J Hum Hypertens; 1989 Jun 28; 3 Suppl 1():139-45. PubMed ID: 2550636
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Circulating angiotensin II levels under repeated administration of lisinopril in normal subjects.
    Kawamura M, Imanashi M, Matsushima Y, Ito K, Hiramori K.
    Clin Exp Pharmacol Physiol; 1992 Aug 28; 19(8):547-53. PubMed ID: 1326422
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics of enalapril and lisinopril in subjects with normal and impaired hepatic function.
    Hayes PC, Plevris JN, Bouchier IA.
    J Hum Hypertens; 1989 Jun 28; 3 Suppl 1():153-8. PubMed ID: 2550638
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.